AzTrials
AzTrials

ColposcopyNCT03100565

Lidocaine Spray vs Coughing for Pain Relief During Colposcopy

A study testing local lidocaine spray and forced coughing in people with Colposcopy, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cervical cancer is the third most common genital cancer worldwide. The diagnosis of cervical cancer is performed with the cervical biopsy which is guided by the colposcopy. The colposcopy guided cervical biopsy creates pain and several methods have been reported to overcome the pain related with this procedure. Read more about this study

Who is it for?
Ages 18 to 80 years, women only
Conditions the study is for
Colposcopy
What is being tested?
local lidocaine spray and forced coughing
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
96 participants
Where
1 siteTurkey (Türkiye)
Study dates
Sep 2016to 10 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with age >18,
  • Presence of cervix,
  • Patients who need a diagnostic work up for abnormal cervical smear results.

Who cannot join

  • Pregnancy,
  • Presence of already known invasive cancer,
  • Allergy to anesthetic agents.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Yuzuncu Yil University, Medical faculty, department of obstetric and gynecology

    Van, 65000

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Lidocaine Spray With Forced Coughing in Pain Relief During Colposcopy Guided Cervical Biopsy Procedure: A Randomized Controlled Trial

Cervical cancer is the third most common genital cancer worldwide. The diagnosis of cervical cancer is performed with the cervical biopsy which is guided by the colposcopy. The colposcopy guided cervical biopsy creates pain and several methods have been reported to overcome the pain related with this procedure. Local anesthetic agent injection into the cervix has been studied and found to be effective and also, forced coughing was compared with local anesthetic injection and it is found to be more effective. In fact local injections can create the pain by itself.However no study compared the effect of forced coughing to local anesthetic spray. The study aims to evaluate the comparison of forced coughing with local anesthetic spray with respect to perceived pain during colposcopy guided biopsy.

Conditions
Colposcopy
Being tested
local lidocaine spray, forced coughing
Keywords
colposcopy, pain, coughing, anesthetic spray
Medical subject headings
Pain, Cough

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • local lidocaine sprayDrug

    The lidocaine spray will be introduced to the cervix just before the biopsy procedure

  • forced coughingOther

    The patients will be asked to forced coughing during the biopsy procedure

Study groups in NCT03100565
Study groupRoleWhat they receive
colposcopic biopsy under local anesthetic spPlacebo comparatorNot described
Receives: Drug: local lidocaine spray
Patients underwent colposcopic biopsy under forced coughingPlacebo comparatorNot described
Receives: Other: forced coughing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain during procedure evaluated by the 0-10 cm scale of Visual analog scale (VAS) scoring system

    The perceived pain will be measured during the biopsy procedure. It will be evaluated by the 0-10 cm scale of VAS scoring system. The patient will be asked to rate her pain as 0 corresponds ''no pain'' and 10 to the '' worst pain''

    Measured: 0-1 min

Secondary outcomes (1)
  1. Pain at the 30th minutes after the procedure evaluated by the 0-10 cm scale of VAS scoring system

    The perceived pain will be measured after the biopsy procedure (at the 30th min). It will be evaluated by the 0-10 cm scale of VAS scoring system. The patient will be asked to rate her pain as 0 corresponds ''no pain'' and 10 to the '' worst pain''

    Measured: 30. Min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2017
  2. Study startSep 2016
  3. Primary completion8 Mar 2018
  4. Study completion10 Mar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
96 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03100565
Sponsor's protocol ID
YuzuncuYıl
Status last verified
Mar 2018
First submitted
17 Mar 2017
Last updated
13 Mar 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing local lidocaine spray and forced coughing in people with Colposcopy, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain during procedure evaluated by the 0-10 cm scale of Visual analog scale (VAS) scoring system (time frame: 0-1 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in